Commentary: Sudden death in competitive student-athletes with hypertrophic cardiomyopathy at a crossroads: Critical views on liberalizing return-to-play eligibility

Diverse issues surrounding the unexpected arrhythmic sudden deaths (SD) of young athletes, have been studied intensely by cardiologists, internists, pediatricians, primary care and sports medicine physicians, and pathologists since 1980, with documentation of several cardiovascular causes, prominently including hypertrophic cardiomyopathy (HCM) (Figure 1) (1).